CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of EUR 340.01 million. The enterprise value is 328.02 million.

Market Cap	340.01M
Enterprise Value	328.02M

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.89%
Owned by Institutions (%)	61.39%
Float	19.82M

Valuation Ratios

The trailing PE ratio is 24.83 and the forward PE ratio is 21.34.

PE Ratio	24.83
Forward PE	21.34
PS Ratio	5.02
PB Ratio	4.41
P/TBV Ratio	5.84
P/FCF Ratio	21.56
P/OCF Ratio	19.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.66, with an EV/FCF ratio of 20.80.

EV / Earnings	23.95
EV / Sales	4.80
EV / EBITDA	15.66
EV / EBIT	18.12
EV / FCF	20.80

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.03.

Current Ratio	3.31
Quick Ratio	2.43
Debt / Equity	0.03
Debt / EBITDA	0.12
Debt / FCF	0.16
Interest Coverage	31.85

Financial Efficiency

Return on equity (ROE) is 18.70% and return on invested capital (ROIC) is 14.74%.

Return on Equity (ROE)	18.70%
Return on Assets (ROA)	12.03%
Return on Invested Capital (ROIC)	14.74%
Return on Capital Employed (ROCE)	20.93%
Revenue Per Employee	293,065
Profits Per Employee	59,284
Employee Count	219
Asset Turnover	0.73
Inventory Turnover	2.03

Taxes

In the past 12 months, CellaVision AB has paid 3.60 million in taxes.

Income Tax	3.60M
Effective Tax Rate	20.82%

Stock Price Statistics

The stock price has decreased by -23.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.36%
50-Day Moving Average	15.49
200-Day Moving Average	15.82
Relative Strength Index (RSI)	39.50
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of EUR 67.70 million and earned 13.69 million in profits. Earnings per share was 0.57.

Revenue	67.70M
Gross Profit	46.79M
Operating Income	17.94M
Pretax Income	17.30M
Net Income	13.69M
EBITDA	19.67M
EBIT	17.94M
Earnings Per Share (EPS)	0.57

Full Income Statement

Balance Sheet

The company has 14.35 million in cash and 2.47 million in debt, giving a net cash position of 11.89 million.

Cash & Cash Equivalents	14.35M
Total Debt	2.47M
Net Cash	11.89M
Net Cash Per Share	n/a
Equity (Book Value)	77.02M
Book Value Per Share	3.23
Working Capital	26.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.65 million and capital expenditures -1.87 million, giving a free cash flow of 15.77 million.

Operating Cash Flow	17.65M
Capital Expenditures	-1.87M
Free Cash Flow	15.77M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.11%, with operating and profit margins of 26.50% and 20.23%.

Gross Margin	69.11%
Operating Margin	26.50%
Pretax Margin	25.55%
Profit Margin	20.23%
EBITDA Margin	29.06%
EBIT Margin	26.50%
FCF Margin	23.30%

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 1.60%.

Dividend Per Share	0.23
Dividend Yield	1.60%
Dividend Growth (YoY)	18.98%
Years of Dividend Growth	n/a
Payout Ratio	39.38%
Buyback Yield	n/a
Shareholder Yield	1.60%
Earnings Yield	4.03%
FCF Yield	4.64%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7